Zynerba Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights
The company reported financial results for the second quarter ended June 30, 2019.
Read More
Select Page
Posted by Invest In Weed | Aug 6, 2019
The company reported financial results for the second quarter ended June 30, 2019.
Read MorePosted by Invest In Weed | Aug 1, 2019
The quarterly payment will increase to $0.58 per share.
Read MorePosted by Invest In Weed | Aug 1, 2019
Q1 Revenues Gain 58% Compared to Prior Year.
Read MorePosted by Invest In Weed | Jul 31, 2019
U.S. Consumer segment sales increase 10% in Q3, up 9% year-to-date.
Read MorePosted by Invest In Weed | Jul 29, 2019
The redemption price for the notes, payable in cash, will include a make-whole premium of...
Read MoreGet stock alerts, news & related alerts straight to your inbox!